LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 482 | 3148 | 0.1531 | -0.2040 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 916 | 11103 | 0.0825 | -0.2039 |
SK-BR-3 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 2543 | 1983 | 5418 | 0.3664 | -0.2038 |
MCF 10A | Geldanamycin | 10 | uM | LJP5 | 72 | hr | 1694 | 925 | 11103 | 0.0833 | -0.2033 |
MDA-MB-231 | PHA-665752 | 10 | uM | LJP5 | 72 | hr | 1311 | 844 | 5079 | 0.1662 | -0.2026 |
Hs 578T | WZ3105 | 0.04 | uM | LJP5 | 72 | hr | 765 | 483 | 3148 | 0.1534 | -0.2022 |
MCF7 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1389 | 896 | 5445 | 0.1651 | -0.1996 |
MCF 10A | Omipalisib | 10 | uM | LJP6 | 72 | hr | 1694 | 925 | 11217 | 0.0825 | -0.1994 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 72 | hr | 765 | 491 | 3101 | 0.1583 | -0.1974 |
Hs 578T | PF431396 | 10 | uM | LJP5 | 72 | hr | 765 | 489 | 3148 | 0.1554 | -0.1970 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1334 | 954 | 3925 | 0.2432 | -0.1966 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 866 | 4935 | 0.1756 | -0.1954 |
BT-20 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 945 | 4033 | 0.2344 | -0.1947 |
SK-BR-3 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 2543 | 1972 | 5752 | 0.3429 | -0.1943 |
SK-BR-3 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 2543 | 1973 | 5752 | 0.3430 | -0.1941 |
MDA-MB-231 | WZ3105 | 0.04 | uM | LJP5 | 72 | hr | 1311 | 862 | 5079 | 0.1699 | -0.1937 |
SK-BR-3 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 2543 | 2013 | 5418 | 0.3717 | -0.1933 |
BT-20 | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 949 | 4033 | 0.2352 | -0.1930 |
MCF7 | BI-2536 | 10 | uM | LJP6 | 72 | hr | 1389 | 912 | 5445 | 0.1676 | -0.1930 |
MDA-MB-231 | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1311 | 874 | 4935 | 0.1771 | -0.1925 |
MCF7 | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 890 | 5905 | 0.1508 | -0.1921 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 765 | 497 | 3101 | 0.1604 | -0.1920 |
Hs 578T | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 765 | 495 | 3148 | 0.1574 | -0.1919 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1311 | 865 | 5079 | 0.1705 | -0.1917 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 874 | 4935 | 0.1773 | -0.1913 |